Description: Occasionally, in the financial reporting world the stars align, and insurers get the opportunity to leverage their financial results and cashflows across multiple reporting use cases. Such opportunity came about with implementation of the U.S. generally accepted accounting practices (GAAP) long-duration targeted improvements (LDTI) accounting standard, that required companies to move away from locked-in assumptions for traditional life and limited-pay products and produce best estimate liability cashflows for these business lines.

Description: This session will delve into the valuable lessons learned from recent accounting change implementation, covering both model and process optimization. Attendees will gain industry knowledge as we explore optimization decisions made by others, highlighting both successful strategies and areas for improvement. We will discuss key decision points throughout the entire actuarial process, including data manipulation, actuarial calculation engine, and post-model reporting.

Description: This session will review reinsurance fundamentals, risk assessment techniques, optimization strategies, and regulatory considerations through case studies and best practices. Attendees will gain insights into enhancing capital management, risk mitigation, and improving operating results, utilizing practical insights from both reinsurers and direct experience.

Description: Insurance companies are substantially transforming their finance operating model. This is mainly trigged by the prevailing changes in the insurance regulatory landscape that are leaning towards principle-based reporting and valuation, which is leading to a significant increase in the effort needed for regulatory and management reporting.

Description: Medical pharmacy is a rapidly evolving, innovative part of healthcare in the United States that includes Oncology, Gene, and Rare disease therapies. Over the past few years, cost and utilization trends have been disrupted by biosimilars, innovative therapies, site of care options, and the COVID-19 pandemic. This volatility can make assumption setting difficult, so take a deep dive into quantifying these impacts on the drug landscape. Gain an understanding of the significance of managing site of care. Learn through adjusted time-series forecasting where medical pharmacy drug spend is expected to grow with new drugs in the pipeline. Walk away with a better understanding of the market forces and care practices that drive trend, and how medical pharmacy is expected to change in the coming years.

Description: You’ve written the position papers, updated the models, and designed the required disclosures, but you may be wondering how to explain the results during interim financial reporting periods to company management as well as other stakeholders. This session will explore ways to adapt existing management reporting and offer ideas for new metrics. We will explore various methods for analyzing DAC amortization patterns, market risk benefit reserve patterns, and Liability for Future Benefits (LFPB) movements. In addition, this session will explore ways to integrate changes in LDTI with business planning and other broader business issues such as product pricing considerations and reinsurance strategy.

Description: Join us for an analysis of the impact of climate change on financial institution solvency, profitability, and how other key performance metrics are, or likely will be, required by financial regulators in most major economies in the very near future. Regulators are signaling that such impacts should be assessed through the use of scenario analysis, both qualitatively and quantitatively. Explore an overview of the emerging regulatory landscape for insurers as it relates to the disclosure of climate risk. After that, check out the mechanics and current best practices that actuaries and risk modelers may use in performing qualitative and quantitative climate risk scenario analyses, covering both physical and transition risks.

Description: Investing for retirement in other countries is different from investing for retirement in the U.S. and Canada. In developing countries, there are fewer investment opportunities and domestic markets are smaller and less liquid. National retirement systems may be established in part to support government debt issuance and to help develop domestic capital markets. Investment policy objectives tend to evolve over time as a country and its retirement system(s) develop together. Come broaden your horizons by painting a picture of a different investment paradigm than you are used to using examples from many countries around the world.

Description: In this video, Chris Smith ASA MAAA, a health actuarial consultant and data science enthusiast, introduces the basics of machine learning and its applications in actuarial science. He covers various techniques, such as unsupervised, supervised, and reinforcement learning, as well as neural networks and gradient boosting. He also discusses the potential risks and ethical considerations of using these advanced technologies in the actuarial field. Contributors: Chris Smith, ASA, MAAA, Jason Reed, FSA, MAAA, Mitchell Momanyi FSA MAAA, Jessica Calafell, FSA, MAAA; Jon Forster ASA, MAAA

Description: Court is in session and you are the jury! Follow along as challenging aspects of actuarial professionalism are explored in a court-like setting. Deliberate based on what you already know from your own experience as well as what you learn in this session, and then deliver your verdict accordingly. New cases will be developed for this meeting. If you attended in the past, plan on joining again as we will have new material for discussion. Who says learning about actuarial professionalism can't also be fun?